SCHEMBL6802209

SCHEMBL6802209

CCc1ccc(C(=COC(F)F)C(=O)NCCc2ccc(O)c(OC)c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOX4 Q9NPH5 1/20 0.48
TYR P14679 1/20 0.48
ACHE P22303 1/20 0.48
HDAC1 Q13547 2/20 0.47
HDAC6 Q9UBN7 2/20 0.47
MTNR1A P48039 1/20 0.47
MTNR1B P49286 1/20 0.47
ALOX5 P09917 1/20 0.45
OR51E2 Q9H255 1/20 0.45
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC9 Q9UKV0 1/20 0.44
HDAC5 Q9UQL6 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6802206 1.00 NOX4 (0.48) NOX4TYRACHEHDAC1HDAC6
SCHEMBL6803649 0.92 NOX4 (0.48) NOX4TYRACHEHDAC1HDAC6
SCHEMBL6807707 0.92 MAPT (0.48) NOX4TYRACHEHDAC1HDAC6
SCHEMBL6807705 0.92 MAPT (0.48) NOX4TYRACHEHDAC1HDAC6
SCHEMBL6797885 0.92 ALDH1A1 (0.52) NOX4TYRACHEHDAC1HDAC6
SCHEMBL6797880 0.92 ALDH1A1 (0.52) NOX4TYRACHEHDAC1HDAC6
SCHEMBL6803651 0.92 NOX4 (0.48) NOX4TYRACHEHDAC1HDAC6
SCHEMBL6798750 0.91 GAA (0.53) NOX4TYRACHEHDAC1HDAC6
SCHEMBL6798746 0.91 GAA (0.53) NOX4TYRACHEHDAC1HDAC6
SCHEMBL6798948 0.91 GAA (0.53) NOX4TYRACHEHDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6762321-B2 SUCH AS N-(2-(3,4-DIMETHOXYPHENYL)ETHYL)-3-DIFLUOROMETHOXY-2-(4 -METHYLPHENYL)ACRYLAMIDE; FUNGICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-07-13 US disclosed
US-20030195354-A1 Amide compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-10-16 US disclosed
EP-1295868-A1 AMIDE COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-03-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030195354-A1 Amide compounds and use thereof CBR1, CBR3, NAT1 NOX4 331/4885TYR 967/4885ACHE 470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.